Filing Details
- Accession Number:
- 0001209191-17-025624
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-04-05 16:15:52
- Reporting Period:
- 2017-04-03
- Filing Date:
- 2017-04-05
- Accepted Time:
- 2017-04-05 16:15:52
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 907654 | Arca Biopharma Inc. | ABIO | In Vitro & In Vivo Diagnostic Substances (2835) | 363855489 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1628992 | L. Brian Selby | 11080 Circlepoint Road Suite 140 Westminster CO 80020 | Vp, Finance | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2017-04-03 | 1,114 | $2.46 | 1,275 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- Represents shares of common stock sold pursuant to a Rule 10b5-1 Plan adopted by the Reporting Person with respect to the vesting of previously reported Restricted Stock Units ("RSUs") granted to the Reporting Person under the Issuer's 2013 Amended and Restated Equity Incentive Plan (the "Plan").
- Includes (i) remaining 161 previously reported shares issued as RSUs under the Plan that vest on 2/27/18, and (ii) remaining 1,114 previously reported shares issued as RSUs under the Plan that vest on 4/2/18, provided that the Reporting Person's continuous service to the Issuer has not been terminated as defined under the Plan.
Billionaire Hedge Funds
